Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950170-25-020385
Filing Date
2025-02-14
Accepted
2025-02-14 07:00:04
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 13327
2 EX-99.A ck0001910592-ex99_a.htm EX-99.A 13766
  Complete submission text file 0000950170-25-020385.txt   28851
Mailing Address 299 PARK AVE 21ST FLOOR NEW YORK NY 10171
Business Address 299 PARK AVE 21ST FLOOR NEW YORK NY 10171 212 832 4111
Harraden Circle Investments, LLC (Filed by) CIK: 0001910592 (see all company filings)

EIN.: 813057945 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address 121 RICHMOND STREET WEST PENTHOUSE SUITE 1300 TORONTO A6 M5H 2K1
Business Address 121 RICHMOND STREET WEST PENTHOUSE SUITE 1300 TORONTO A6 M5H 2K1 27744604171
PSYENCE BIOMEDICAL LTD. (Subject) CIK: 0001985062 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 0331
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-94325 | Film No.: 25623135
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)